X

Trial Profile

A study evaluating effects of coronary artery revascularization with Buofreedom stent before elective surgery.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 27 Nov 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Umirolimus (Primary)
Indications Coronary artery restenosis
Focus Therapeutic Use

Most Recent Events

27 Nov 2017 New trial record
15 Nov 2017 Primary endpoint (Period of planned operation after revascularization) has been met as per the results presented at the 90th Annual Scientific Sessions of the American Heart Association
15 Nov 2017 Primary endpoint (Occurrence of the composite clinical endpoints) has been met as per the results presented at the 90th Annual Scientific Sessions of the American Heart Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com